retatrutide diabetes – The New Weight Loss Helper Retatrutide is a new medication being developed by Eli Lilly to help people lose weight. It's like a super version of drugs such as Ozempic Retatrutide and the Grey Market:

It is not suitable for individuals with: A personal or family history of medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Severe kidney disease without medical consultation Always consult your healthcare provider to determine if GLP-1 is right for you

At DevotedDOc , the answer is yes

This is one of the most psychologically challenging moments in the entire GLP-1 journey, and it is also one of the most misunderstood

Vitamin B12 monitoring is particularly important for patients also taking metformin, as both medications can affect B12 status

GLP-2R transcripts are expressed in human colorectal tumors (Koehler et al., 2015) and GLP-2R protein is expressed in human colon neoplasms (Koehler et al., 2008) (Table 3)